Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;13(1):34-40.
doi: 10.1177/1932296818795150. Epub 2018 Aug 22.

Patch Pumps: Are They All the Same?

Lutz Heinemann  1 , Delia Waldenmaier  2 , Bernd Kulzer  3 , Ralph Ziegler  4 , Barry Ginsberg  5 , Guido Freckmann  2
Affiliations
Review

Patch Pumps: Are They All the Same?

Lutz Heinemann et al. J Diabetes Sci Technol. 2019 Jan.

Abstract

Insulin pumps are used by a steadily increasing number of patients with diabetes. Avoiding certain disadvantages of conventional pumps (ie, the insulin infusion set) might make pump therapy even more attractive. Patch pumps are usually attached by means of an adhesive layer to the skin and have several additional advantages (smaller, more discrete, easier to use, and cheaper than conventional insulin pumps). This review provides a general overview of patch pumps, the technologies used, basic clinical requirements, why a number of developments failed, which clinical studies are needed to provide sufficient evidence for their usage, which costs are associated, what the patient preferences are (which might differ between certain patient groups), and what is the future of patch pumps (ie, artificial pancreas systems).

Keywords: infusion sets; insulin pumps; insulin therapy; patch pumps.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: All authors received support for writing this article from an unrestricted grant by Roche Diabetes Care, Mannheim, Germany.

References

    1. Pickup JC, Yemane N, Brackenridge A, Pender S. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabetes Technol Ther. 2014;16(3):145-149. - PMC - PubMed
    1. Peyrot M, Dreon D, Zraick V, Cross B, Tan MH. Patient perceptions and preferences for a mealtime insulin delivery patch. Diabetes Ther. 2018;9(1):297-307. - PMC - PubMed
    1. Heinemann L, Krinelke L. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol. 2012;6(4):954-964. - PMC - PubMed
    1. Deiss D, Adolfsson P, Alkemade-van ZM, et al. Insulin infusion set use: European perspectives and recommendations. Diabetes Technol Ther. 2016;18(9):517-524. - PMC - PubMed
    1. Payne FW, Ledden B, Lamps G. Capabilities of next-generation patch pump: improved precision, instant occlusion detection, and dual-hormone therapy. J Diabetes Sci Technol. 2019;13:49-54. - PMC - PubMed

Publication types

MeSH terms